$1.96
-0.03-1.51%
Dern. MÀJ: Oct 30, 5:32 PM
Zentalis Pharmaceuticals (ZNTL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.46 | $-0.52 | $-0.53 | $-0.48 |
| Actual | $-0.59 | $-0.50 | $-0.49 | $-0.37 |
| Surprise | -28.3% | +3.85% | +7.55% | +22.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.53 | $-0.51 | $-0.56 | $-0.55 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.59 | $-0.46 | -28.3 % |
| Q1 | May 12, 2026 | $-0.50 | $-0.52 | 3.85 % |
| Q4 | Mar 26, 2026 | $-0.49 | $-0.53 | 7.55 % |
| Q3 | Nov 10, 2025 | $-0.37 | $-0.48 | 22.9 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q1 | May 7, 2024 | $40.56M | $13.12M | 209.1 % |